Importance Cerebral palsy (CP) is the most common childhood physical disability. Early
intervention for children younger than 2 years with or at risk of CP is critical. Now that an …

Cerebral palsy (CP) is defined as a nonprogressive motor disorder with impaired movement
or posture that is the result of an injury or anomaly of the developing brain (generally …

Sleep deficiency has unique causes and implications for children with neonatal brain injury;
contributing to the development or exacerbation of neurodevelopmental impairments and …

Objective To develop an algorithm for the selection of adults with disabling spasticity for
treatment with intrathecal baclofen (ITB) and/or botulinum toxin type A (BoNT A). Methods A …

Background: Neuropathic pain is one of the most common problems in patients with
diabetes mellitus (DM). In this study, the effect of botulinum toxin type A (BTX-A) on …

Background Children with cerebral palsy (CP) are more likely to experience sleep problems.
Their sleep difficulties have been shown to be related to poorer sleep quality for their …

Objective To determine physical activity, sleep, and nutrition patterns in individuals with
cerebral palsy (CP) and investigate the association of Gross Motor Function Classification …

Objective: To describe the current state of the art in the therapeutic administration of
botulinum toxin with indications, efficacy, and safety profile for children and adolescents with …

Children with cerebral palsy (CP) are at higher risk for sleep disturbances than their typically
developing peers. In typically developing young children, lack of sufficient sleep results in …

Background and purpose: Botulinum toxin (BoNT) is a commonly used agent in the
treatment of stroke-related spasticity. Sleep disorders can often be seen as a comorbidity or …